Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Martus

Showing results (391-400 of 437) with videos related to

Pageof 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2019
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel NodeUlrike Leiter, Rudolf Stadler, Cornelia Mauch, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Stroke|April 23, 2015
Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular eventFranz Fazekas, Christian Enzinger, Reinhold Schmidt, et al.
BMJ Open|June 1, 2022
Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial ReductAlexander Bäuerle, Peter Martus, Yesim Erim, et al.
Trials|July 23, 2022
Supporting families to achieve a healthy weight development for their child with overweight/obesity using the STARKIDS intervention: study protocol for a cluster-randomized controlled trialKatrin Ziser, Florian Junne, Anne Herschbach, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Annals of Neurology|February 10, 2016
Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patientsRebecca Schüle, Sarah Wiethoff, Peter Martus, et al.
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trialCihan Gani, Emmanouil Fokas, Bülent Polat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Nature Cancer|June 4, 2026
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trialGhazaleh Tabatabai, Isabel Ramirez, Beatrix Welte, et al.
Pageof 44

Showing results (391-400 of 437) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2019
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel NodeUlrike Leiter, Rudolf Stadler, Cornelia Mauch, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Stroke|April 23, 2015
Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular eventFranz Fazekas, Christian Enzinger, Reinhold Schmidt, et al.
BMJ Open|June 1, 2022
Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial ReductAlexander Bäuerle, Peter Martus, Yesim Erim, et al.
Trials|July 23, 2022
Supporting families to achieve a healthy weight development for their child with overweight/obesity using the STARKIDS intervention: study protocol for a cluster-randomized controlled trialKatrin Ziser, Florian Junne, Anne Herschbach, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Annals of Neurology|February 10, 2016
Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patientsRebecca Schüle, Sarah Wiethoff, Peter Martus, et al.
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trialCihan Gani, Emmanouil Fokas, Bülent Polat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Nature Cancer|June 4, 2026
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trialGhazaleh Tabatabai, Isabel Ramirez, Beatrix Welte, et al.
Pageof 44